Physician profile
Holly A Everett
NPI 1306478870
$923.07
in general payments reported to CMS, 2019-2025
18 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.46 · 2022: $72.13 · 2023: $389 · 2024: $244 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $146.73 | 2023 | Myrisk |
| Otsuka America Pharmaceutical, INC. | $139.07 | 2022-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $75.17 | 2025 | Caplyta |
| Pfizer INC. | $69.44 | 2022-2024 | |
| Astellas Pharma US INC | $57.65 | 2023-2024 | Veozah |
| Lilly USA, LLC | $53.45 | 2024 | Mounjaro |
| Viatris Specialty LLC | $49.33 | 2025 | Yupelri |
| Exact Sciences Corporation | $42.99 | 2025 | The Cologuard Plus Collection Kit |
| Dexcom, INC. | $41.48 | 2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $40.97 | 2024 | |
| Phathom Pharmaceuticals, INC. | $30.69 | 2024 | Voquezna |
| Janssen Pharmaceuticals, INC | $28.57 | 2023 | Spravato |
| Novartis Pharmaceuticals Corporation | $28.39 | 2023 | |
| Abbott Laboratories | $27.63 | 2023 | Freestyle Libre 2 |
| Amarin Pharma, INC. | $27.46 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $26.24 | 2022-2024 | Ingrezza |
| Lundbeck LLC | $23.10 | 2025 | Rexulti |
| Novo Nordisk INC | $14.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.